Outside-to-Inside Signal Through the Membrane TNF-α Induces E-Selectin (CD62E) Expression on Activated Human CD4+ T Cells1

The membrane TNF-α is known to serve as a precursor of the soluble form of TNF-α. Although it has been reported the biological functions of the membrane TNF-α as a ligand, the outside-to-inside (reverse) signal transmitted through membrane TNF-α is poorly understood. Here we report a novel function mediated by outside-to-inside signal via membrane TNF-α into the cells expressing membrane TNF-α. Activation by anti-TNF-α Ab against membrane TNF-α on human T cell leukemia virus (HTLV) I-infected T cell line, MT-2, or PHA-activated normal human CD4+ T cells resulted in the induction of an adhesion molecule, E-selectin (CD62E), on the cells with the peak of 12–24 h, which completely disappeared by 48 h. When wild-type or mutant membrane TNF-α (R78T/S79T) resistant to proteolytic cleavage was introduced into Jurkat or HeLa cells, E-selectin was induced by the treatment with anti-TNF-α Ab with the similar kinetics. Membrane TNF-α-expressing Jurkat cells also up-regulated E-selectin when brought into cell-to-cell contact with TNF receptor-expressing HeLa cells. Northern blot analysis and RT-PCR analysis showed that the membrane TNF-α-mediated E-selectin expression was up-regulated at the level of transcription. These results not only confirmed our previous findings of reverse signaling through membrane TNF-α, but also presented evidence that E-selectin was inducible in cell types different from endothelial cells. It is strongly suggested that membrane TNF-α is a novel proinflammatory cell surface molecule that transmits bipolar signals in local inflammation.

[1]  T. Horiuchi,et al.  C5a Induces Tissue Factor Activity on Endothelial Cells , 1997, Thrombosis and Haemostasis.

[2]  T. Horiuchi,et al.  Membrane Tumor Necrosis Factor-α (TNF-α) Expressed on HTLV-I-Infected T Cells Mediates a Costimulatory Signal for B Cell Activation—Characterization of Membrane TNF-α , 1997 .

[3]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.

[4]  J. Berman,et al.  Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes , 1992, Journal of Experimental Medicine.

[5]  B. Beutler,et al.  Unraveling function in the TNF ligand and receptor families. , 1994, Science.

[6]  M. Sheetz,et al.  Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes. , 1997, Journal of immunology.

[7]  B. Beutler,et al.  The tumor necrosis factor ligand and receptor families. , 1996, The New England journal of medicine.

[8]  J. Volanakis,et al.  Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA. , 1990, The Journal of biological chemistry.

[9]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[10]  M. Brockhaus,et al.  Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. , 1989, Cellular immunology.

[11]  D. Wallach,et al.  Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. , 1995, Journal of inflammation.

[12]  G. Aversa,et al.  The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation , 1993, The Journal of experimental medicine.

[13]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[14]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[15]  E. Maggi,et al.  Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells , 1993, Nature.

[16]  S. Inaba,et al.  A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese. , 1998, Journal of immunology.

[17]  Mengji Lu,et al.  Molecular cloning of the woodchuck cytokines: TNF-α, IFN-γ, and IL-6 , 1998, Immunogenetics.

[18]  R. Medford,et al.  E-selectin gene expression in vascular smooth muscle cells. Evidence for a tissue-specific repressor protein. , 1997, Circulation research.

[19]  G S Kansas,et al.  Selectins and their ligands: current concepts and controversies. , 1996, Blood.

[20]  C. Ferran,et al.  Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. , 1994, The Journal of clinical investigation.

[21]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.

[22]  M. Lambert,et al.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.

[23]  T. Horiuchi,et al.  Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese. , 1999, Rheumatology.

[24]  G. Grau,et al.  Both soluble and membrane-associated TNF activate brain microvascular endothelium: relevance to multiple sclerosis , 1997, Molecular Psychiatry.

[25]  C. Smith,et al.  Reverse signaling via CD30 ligand. , 1996, Journal of immunology.

[26]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[27]  D E Ingber,et al.  Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton , 1996, The Journal of cell biology.

[28]  R. Swerlick,et al.  Alternatively processed human E-selectin transcripts linked to chronic expression of E-selectin in vivo. , 1994, Journal of immunology.

[29]  D. Gray,et al.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.

[30]  M. Feldmann,et al.  Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha. , 1997, Journal of immunology.

[31]  J. Gamble,et al.  Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. , 1993, Journal of immunology.

[32]  M. Gimbrone,et al.  Novel Roles for E‐Selectin in Endothelial‐Leukocyte Adhesion a , 1997, Annals of the New York Academy of Sciences.

[33]  David Wallach,et al.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’ , 1999, The EMBO journal.

[34]  R. Kriz,et al.  The cloning of CD70 and its identification as the ligand for CD27. , 1994, Journal of immunology.

[35]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[36]  T. Decker,et al.  Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. , 1987, Journal of immunology.

[37]  W. Fiers,et al.  Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.

[38]  R. Hakem,et al.  Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling , 1999, Immunological reviews.

[39]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.